The value of phenylbutazone in the treatment of rheumatoid arthritis as determined by clinical response and by the serum protein-polysaccharide ratio (PR). [electronic resource]
- The Journal of laboratory and clinical medicine Mar 1955
- 331-9 p. digital
Publication Type: Journal Article
0022-2143
Analgesics--therapeutic use Arthritis Arthritis, Rheumatoid--therapy Blood Proteins Phenylbutazone Polysaccharides--blood